CAPITAL STRUCTUREFast Moving Consumer Goods

Anondita Medi. moves to reshape its capital structure

Anondita Medi.ANONDITA

TL;DR

The proposed rights issue is large relative to the company’s existing equity base, but the disclosed operating use is only a partial allocation. The company has proposed a rights issue of up to Rs 109.78 Crores; the identifiable end-use is Rs 29.9 Crores of net fresh proceeds for machinery and equipment to expand capacity at its Kavathe and Shirwal facilities.

What is the specific end-use of proceeds outlined in the Rights Issue proposal, and how does this capital infusion compare to the company's current debt-to-equity ratio and working capital requirements as reported in the latest financial statements?

The proposed rights issue is large relative to the company’s existing equity base, but the disclosed operating use is only a partial allocation. The company has proposed a rights issue of up to Rs 109.78 Crores; the identifiable end-use is Rs 29.9 Crores of net fresh proceeds for machinery and equipment to expand capacity at its Kavathe and Shirwal facilities. The cited disclosure is truncated after these locations, and the complete allocation across the issue proceeds is not available; issue terms were also reported as undisclosed at the approval stage. [1] [2]

Capital structure and liquidity comparison

Interpretation: On a full-subscription basis, and assuming the proceeds are added to equity without debt repayment, the borrowings-to-equity proxy would fall mechanically to approximately 0.45x, derived from Rs 130.74 Crores of borrowings divided by post-issue equity of Rs 290.66 Crores. [4] [3] [2] This would materially strengthen the balance-sheet ratio, but it would not close the company’s Rs 910.06 Crores negative working-capital gap. The proposed issue equals only about 12.06% of that gap, and the specifically identified Rs 29.9 Crores machinery allocation is primarily growth/capacity capital rather than liquidity support. [1]

Key caveat: the 0.72x debt-to-equity figure is a proxy, because the supplied statements identify non-current borrowings but do not provide a separate current-borrowings figure. Total debt-to-equity could therefore be higher if current borrowings are outstanding. The stated working-capital deficit also reflects balance-sheet current assets and liabilities; the actual portion of rights proceeds earmarked for working capital has not been separately disclosed.

MeasureCalculationResult
Proposed rights issue vs existing equityRs 109.78 Crores / Rs 180.88 Crores60.69% of latest consolidated equity [2] [3]
Debt-to-equity proxyRs 130.74 Crores non-current borrowings / Rs 180.88 Crores equity0.72x or 72.28% [4] [3]
Proposed issue vs non-current borrowingsRs 109.78 Crores / Rs 130.74 Crores83.99% [2] [4]
Net working capitalRs 537.44 Crores current assets − Rs 1,447.50 Crores current liabilitiesNegative Rs 910.06 Crores, derived [5] [6]
Rights issue vs current-liability baseRs 109.78 Crores / Rs 1,447.50 Crores7.59% [2] [6]
Current ratioCurrent assets / current liabilities0.37x [7]

Regarding the auditor appointment, does the filing specify this as a routine rotation under Companies Act provisions, or does it follow a resignation that necessitates a review of the previous auditor's last limited review report for any qualified opinions?

The basis of the auditor appointment cannot be determined from the filing extract available here. It does not contain the relevant appointment resolution or explanatory statement, so there is no evidence to classify it as either:

  • a routine rotation under the Companies Act; or
  • an appointment following the previous auditor’s resignation.

Accordingly, a review of the previous auditor’s last limited review report for qualifications cannot be confirmed as applicable from the available record. The decisive disclosure would be whether the filing refers to the previous auditor’s retirement/rotation or explicitly records a resignation and appointment to fill the resulting vacancy.

What is the current headroom in the company's authorized share capital, and does the board's Rights Issue proposal necessitate a prior shareholder resolution to increase the authorized capital limit before the issue size and ratio can be finalized?

The latest explicit capital disclosure implies headroom of Rs 1.91 Crores, calculated as authorized share capital of Rs 20.00 Crores less paid-up capital of Rs 18.09 Crores [8]. At the Rs 10 face value disclosed for the company’s proposed equity shares, this equates to approximately 19.13 lakh additional shares [9].

The shareholder-resolution requirement is conditional, not automatic:

  • If the Rights Issue’s nominal value—number of shares multiplied by face value—fits within the approximately Rs 1.91 Crores available headroom, a prior increase in authorized capital is not required merely because the issue is a Rights Issue.
  • If the proposed number of Rights Issue shares exceeds approximately 19.13 lakh Rs 10 shares, the company would first need shareholder approval to increase the authorized capital limit and amend the relevant capital clause. The board cannot itself expand that limit.
  • The resolution is therefore a prerequisite to issuing or allotting shares beyond the current limit. The board could announce or structure a proposal subject to that approval, but the final issue cannot be implemented beyond the authorized capital until the increase is approved and completed.

The proposal’s final size and ratio cannot yet be tested against this headroom. The company’s Rights Issue process was still at the stage of fixing the record date, price and entitlement ratio [10]; the cited NSE approval report does not state the aggregate issue amount [11].

Important reconciliation point: the KPI data reports latest equity share capital of Rs 88.64 Crores [12], which is inconsistent with the separate disclosure of Rs 20.00 Crores authorized capital and Rs 18.09 Crores paid-up capital [8]. Accordingly, Rs 1.91 Crores should be treated as the headroom based on the latest explicit authorized/paid-up figures, not as an unqualified current figure, until the capital records are reconciled. The proposed promoter warrants were described as a proposal rather than evidence of completed allotment or conversion [9].

Sources

  1. [1]Anondita Medicare | Rights > Pharmaceuticals & Drugs ...Moneycontrol, 2026-08-27T16:02:11.731858
  2. [2]Anondita Medicare Receives NSE In-Principle Approval For ₹109.782 Crore Rights Issue | Tijori AlertsTijorialerts, 2026-08-26T00:00:00
  3. [3]Latest Total Equity
  4. [4]Latest Non-Current Borrowings
  5. [5]Latest Current Assets
  6. [6]Latest Current Liabilities
  7. [7]Current Ratio
  8. [8]anondita medicare limited / l22193dl2024plc428183Falconebiz, 2026-03-06T00:00:00
  9. [9]Anondita Medicare Files Newspaper Publication for May 28 EGM NoticeScanx, 2026-05-08T00:00:00
  10. [10]anondita medicare limitedNsearchives, 2026-08-01T00:00:00
  11. [11]Anondita Medicare Ltd. Share Price Today: Live updatesZerodha, 2026-08-26T00:00:00
  12. [12]Latest Equity Share Capital

Keep digging

What is the specific end-use of proceeds outlined in the Rights Issue proposal, and how does this capital infusion compare to the company's current debt-to-equity ratio and working capital requirements as reported in the latest financial statements?

Ask Copilot
Logo

Unlock financial AI for your firm